Ovid Therapeutics Inc. (OVID) Social Stream
Ovid Therapeutics Inc (OVID) Price Targets From Analysts
Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 13 months, OVID's average price target has gone down $0.5.
Over the past 50 weeks, OVID's average upside potential has been 42.98%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OVID Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
OVID's average broker recommendation rating improved by 1.14 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Ovid Therapeutics Inc's average analyst price target is higher than 9.63% of all US stocks.
- In the context of all US stocks, Ovid Therapeutics Inc's number of analysts covering the stock is greater than 43.69% of them.
- OVID has a higher upside potential (average analyst target price relative to current price) than 84.57% of Pharmaceutical Products stocks.
- In the context of stocks in the small market cap category, Ovid Therapeutics Inc's variance in analysts' estimates is lower than -111.74% of them.
What is the outlook for OVID? Use POWR Ratings for clearer insight into price direction.